87 related articles for article (PubMed ID: 11037249)
1. The acceptability of pneumococcal vaccine to older persons in Ireland.
Bedford D; Igoe G; White M; Parsons B; Foyle D; Howell F; Corcoran R
Ir Med J; 2000; 93(2):48-9. PubMed ID: 11037249
[TBL] [Abstract][Full Text] [Related]
2. Influenza and pneumococcal vaccination in older veterans: results from the behavioral risk factor surveillance system.
Chi RC; Reiber GE; Neuzil KM
J Am Geriatr Soc; 2006 Feb; 54(2):217-23. PubMed ID: 16460371
[TBL] [Abstract][Full Text] [Related]
3. Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma--United States, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(43):1007-12. PubMed ID: 15525897
[TBL] [Abstract][Full Text] [Related]
4. Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people.
Ridda I; Lindley IR; Gao Z; McIntyre P; Macintyre CR
Vaccine; 2008 Oct; 26(44):5633-40. PubMed ID: 18706955
[TBL] [Abstract][Full Text] [Related]
5. [Pneumococcal vaccination for persons 65 years of age and older].
van den Bosch WJ
Ned Tijdschr Geneeskd; 2002 May; 146(18):838-9. PubMed ID: 12038219
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and predictors of influenza and pneumococcal vaccine uptake in patients with diabetes.
Clancy U; Moran I; Tuthill A
Ir Med J; 2012 Oct; 105(9):298-300. PubMed ID: 23240281
[TBL] [Abstract][Full Text] [Related]
7. Influenza and pneumococcal immunization rates among a high-risk population.
Chan-Tack KM
South Med J; 2001 Mar; 94(3):323-4. PubMed ID: 11284519
[TBL] [Abstract][Full Text] [Related]
8. Influenza and pneumococcal vaccination levels among persons aged > or = 65 years--United States, 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Jun; 50(25):532-7. PubMed ID: 11446571
[TBL] [Abstract][Full Text] [Related]
9. Influenza season triggers pneumococcal vaccination.
Goebel LJ; Mufson MA
J Am Geriatr Soc; 2006 Aug; 54(8):1261-4. PubMed ID: 16913996
[TBL] [Abstract][Full Text] [Related]
10. Preventing pneumococcal disease. ACIP recommends pneumococcal polysaccharide vaccine for all adults age > or = 65.
Whitney CG
Geriatrics; 2003 Oct; 58(10):20-2, 25. PubMed ID: 14569639
[TBL] [Abstract][Full Text] [Related]
11. Influenza and pneumococcal vaccination coverage among persons aged > or = 65 years--United States, 2004-2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Oct; 55(39):1065-8. PubMed ID: 17021591
[TBL] [Abstract][Full Text] [Related]
12. Influenza and pneumococcal vaccination levels among persons aged > or = 65 years--United States, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(45):1019-24. PubMed ID: 12458918
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with pneumococcal immunisation among hospitalised elderly persons: a survey of patient's perception, attitude, and knowledge.
Ridda I; Motbey C; Lam L; Lindley IR; McIntyre PB; Macintyre CR
Vaccine; 2008 Jan; 26(2):234-40. PubMed ID: 18054818
[TBL] [Abstract][Full Text] [Related]
14. Under usage of conjugate pneumococcal vaccine in the Irish neonatal population.
Breatnach C; McMahon P
Ir Med J; 2007 Jan; 100(1):345. PubMed ID: 17380930
[No Abstract] [Full Text] [Related]
15. An emergency department-based vaccination program: overcoming the barriers for adults at high risk for vaccine-preventable diseases.
Rimple D; Weiss SJ; Brett M; Ernst AA
Acad Emerg Med; 2006 Sep; 13(9):922-30. PubMed ID: 16902048
[TBL] [Abstract][Full Text] [Related]
16. Education does pay off: pneumococcal vaccine screening and administration in hospitalized adult patients with pneumonia.
Kruspe R; Lillis R; Daberkow DW; Blais CM; Wilbright W; Gupta S; Gould CA; Sun T; Martinez JA; deBoisblanc B; Ladabaum U; Sanders CV; Lopez FA
J La State Med Soc; 2003; 155(6):325-31. PubMed ID: 14750752
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
[TBL] [Abstract][Full Text] [Related]
18. A qualitative study to assess the perceived benefits and barriers to the pneumococcal vaccine in hospitalised older people.
Ridda I; Macintyre CR; Lindley RI
Vaccine; 2009 Jun; 27(28):3775-9. PubMed ID: 19464561
[TBL] [Abstract][Full Text] [Related]
19. [Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk].
de Greeff SC; Sanders EA; de Melker HE; van der Ende A; Vermeer PE; Schouls LM
Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1454-7. PubMed ID: 17633974
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: a case-control study.
Dominguez A; Salleras L; Fedson DS; Izquierdo C; Ruiz L; Ciruela P; Fenoll A; Casal J
Clin Infect Dis; 2005 May; 40(9):1250-7. PubMed ID: 15825026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
